Rudin, Charles M., Poirier, John T., Byers, Lauren Averett, Dive, Caroline, Dowlati, Afshin, George, Julie, Heymach, John, V, Johnson, Jane E., Lehman, Jonathan M., MacPherson, David, Massion, Pierre P., Minna, John D., Oliver, Trudy G., Quaranta, Vito, Sage, Julien, Thomas, Roman K., Vakoc, Christopher R. and Gazdar, Adi F. (2019). Molecular subtypes of small cell lung cancer: a synthesis of human and mouse model data. Nat. Rev. Cancer, 19 (5). S. 289 - 298. LONDON: NATURE PUBLISHING GROUP. ISSN 1474-1768

Full text not available from this repository.

Abstract

Small cell lung cancer (SCLC) is an exceptionally lethal malignancy for which more effective therapies are urgently needed. Several lines of evidence, from SCLC primary human tumours, patient-derived xenografts, cancer cell lines and genetically engineered mouse models, appear to be converging on a new model of SCLC subtypes defined by differential expression of four key transcription regulators: achaete-scute homologue 1 (ASCL1; also known as ASH1), neurogenic differentiation factor 1 (NeuroD1), yes-associated protein 1 (YAP1) and POU class 2 homeobox 3 (POU2F3). In this Perspectives article, we review and synthesize these recent lines of evidence and propose a working nomenclature for SCLC subtypes defined by relative expression of these four factors. Defining the unique therapeutic vulnerabilities of these subtypes of SCLC should help to focus and accelerate therapeutic research, leading to rationally targeted approaches that may ultimately improve clinical outcomes for patients with this disease.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Rudin, Charles M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Poirier, John T.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Byers, Lauren AverettUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Dive, CarolineUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Dowlati, AfshinUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
George, JulieUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Heymach, John, VUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Johnson, Jane E.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Lehman, Jonathan M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
MacPherson, DavidUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Massion, Pierre P.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Minna, John D.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Oliver, Trudy G.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Quaranta, VitoUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Sage, JulienUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Thomas, Roman K.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Vakoc, Christopher R.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gazdar, Adi F.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-149971
DOI: 10.1038/s41568-019-0133-9
Journal or Publication Title: Nat. Rev. Cancer
Volume: 19
Number: 5
Page Range: S. 289 - 298
Date: 2019
Publisher: NATURE PUBLISHING GROUP
Place of Publication: LONDON
ISSN: 1474-1768
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
NEUROENDOCRINE DIFFERENTIATION; TRANSCRIPTION FACTOR; INSM1 IA-1; HETEROGENEITY; EXPRESSION; SCLC; ADENOCARCINOMAS; NETWORK; TUMORS; LINESMultiple languages
OncologyMultiple languages
Refereed: Yes
URI: http://kups.ub.uni-koeln.de/id/eprint/14997

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item